ClinTec International has expanded its CRO operations into Malawi, appointing its first highly experienced clinical research associates. Also, a large pharmaceutical company has selected ClinTec as its preferred partner for vaccine development in Africa and Asia.

The company is in the process of recruiting highly skilled personnel with vaccine research experience to join its already established teams in Africa and Asia, in preparation for strong growth ahead from these geographic markets.

Commenting on the opening of ClinTec’s Malawi operations, Dr. Rabinder Buttar stated, “I am pleased with our continued expansion in Africa and see huge potential for the company in conducting large scale vaccine trials. Despite the challenging economic conditions through which many of our clients are restructuring their organizations, ClinTec continues to grow and win major new business from pharma companies. The company is continuing to expand into interesting new regions for clinical research. As the pharmaceutical industry increasingly focuses its drug development efforts on the emerging markets, ClinTec will closely partner with its clients, aligning its services and operations to fit with their needs.”